Regeneron Pharmaceuticals, Inc. XNAS: REGN

Regeneron Pharmaceuticals, Inc. Live Share Price Today, Share Analysis and Chart

Name: Regeneron Pharmaceuticals, Inc.: Is Infosys Ltd. worth buying?
Item: Regeneron Pharmaceuticals, Inc.
Rating: 1.973902625
Author: Trendlyne DVM scores

Slowing Down Stock

Download real time

678.42 11.55 (1.73%)

43.99% Fall from 52W High

845.4K XNAS Volume

XNAS 17 Mar, 2025 5:30 PM (EDT)

Medium Financial Strength

44.4 / 100

Mid Valuation

41.3 / 100

Technically Bearish

27.7 / 100

Slowing Down Stock These stocks score good in Quality and also have medium range financials. However, a bad technical scoring and bearish aspects decrease the investor's interest over time. View Similar Embed DVM

923

1Yr Price target upside is 36%

24 analysts

Regeneron Pharmaceuticals,... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Regeneron Pharmaceuticals, Inc. FAQ

How is Regeneron Pharmaceuticals, Inc. today?

Regeneron Pharmaceuticals, Inc. today is trading in the green, and is up by 1.73% at 678.42.

How has Regeneron Pharmaceuticals, Inc. performed historically?

Regeneron Pharmaceuticals, Inc. is currently trading up 1.73% on an intraday basis. In the past week the stock fell -4.11%. stock has been down -7.80% in the past quarter and fell -29.66% in the past year. You can view this in the overview section.